Efi Cohen-Arazi has over twenty years of experience in the biotech/pharma industry in the areas of drug development and overall business and company management.
He is currently the active chairman of Collplant and serves as board director in a few other biotech companies.
Until July 2006, he was the CEO of Intec Pharma, a drug development company.
Previously, Mr. Cohen-Arazi worked at California-based Amgen Corporation for three years. At Amgen he was respectively Vice-President, Corporate Manufacturing, Head of Contract Manufacturing and Site Head, Thousand Oaks. In his capacity as Head of the Contract Manufacturing Operations at Amgen, he established and led several strategic partnerships for development and manufacturing of small molecules and biopharmaceuticals.
Prior to working with Amgen, Mr. Cohen-Arazi was the Senior Vice President Operations at Immunex, where he developed and implemented strategies to ensure supply of Enbrel ® the company's blockbuster drug.
Mr. Cohen-Arazi worked for more than 12 years in a variety of leadership positions with the Serono Group in Switzerland and Israel and prior to that he was Plant Manager at ABIC Pharmaceutical.
Mr. Cohen-Arazi holds BSc and MSc degrees in Agriculture and Microbiology from the Hebrew University of Jerusalem.
.jpg)
